Word: fda
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Under consideration since last March, the new code was described by FDA Commissioner Charles Edwards as "the most significant change in American marketing since food labeling began." His description is accurate. Some of the new regulations merely clarify or expand existing rules that require only the listing of ingredients (such as beef, salt or flour) in the order of their predominance in a product. Current practice normally does not disclose nutritional components-protein, fat, carbohydrates. Other changes represent substantial shifts in the FDA'S attitudes toward informing the consumer. Among the provisions...
...bread, flour, fortified milk and fruit juices. It must also be included on all products for which nutritional claims are made. Labels must include the serving size and number of servings per container, spell out the caloric, protein, carbohydrate and fat contents and list the percentages of the FDA's recommended daily allowances (RDA) of protein, vitamins and minerals...
...Thanksgiving Day the story of Dean Ebert's Mysteclin-F testimony and the history of his relationship with Squibb broke into the press. Morton Mintz of the Washington Post described the hearings in detail. Mintz reported that the FDA panel turned down Ebert's labelling proposal in executive session. "I don't think they showed efficacy," one scientist said, expressing the unanimous sentiment on the panel against the drug. "The deans' data were marginal at best," said another panel member...
...protection findings is somewhat unusual. It becomes questionable when we learn that the dean has been paid and sponsored by the very pharmaceutical company whose product he is defending. And if the apparent consensus of medical judgement on Mysteclin-F can be trusted, then Ebert's testimony before the FDA failed to damage the interests of medical consumers only because the advisory panel was wise enough to dismiss his arguments...
...view Ebert's Mysteclin-F testimony as an especially dubious exercise of a somewhat dubious consulting prerogative, and we believe that the Dean has traded on the prestige of the Medical School in an attempt to stave off an FDA ban of the drug. Dean Ebert should take his Harvard administrative post off the market by resigning his consulting position at Squibb...